María E Martínez-Muñoz

Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial.

R. Malo de Molina, P. Ussetti, C. Payares-Herrera, 2024, Bone marrow transplantation.

Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial

J. Rubio, R. M. de Molina, R. Sánchez, 2021, Trials.